OBERTAMIG

UNII:	3NCP89Y74H
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	OBERTAMIG
GSRS Full Record:	3NCP89Y74H i

2750126-32-8
Immunoglobulin G1 [263-serine,277-alanine,278-alanine,308-serine,393-valine,409-leucine,435-leucine,437-tryptophan], anti-(human histocompatibility antigen HLA-G α-chain) (human monoclonal MHGB732 single-chain variable fragment VL-(GGSEGKSSGSGSESKSTGGS)-VH) fusion protein with immunoglobulin G1 (human γ1-chain C region C-terminal fragment), (269→229′),(272→232′) bis-(disulfide) with immunoglobulin G4 [237-alanine,238-alanine,268-serine,353-valine,354-tyrosine,408-alanine,410-valine], anti-(human CD3 antigen ε-chain) (human monoclonal CD3B376 γ4-chain) disulfide with human monoclonal CD3B376 λ-chain
Obertamig
immunoglobulin half IG G1-lambda2/scFv-h-CH2-CH3, anti-[Homo sapiens CD3E (CD3 epsilon)] and anti-[Homo sapiens HLA-G (class I major histocompatibility (MH1) antigen G, human leucocyte antigen G) C-like domain], Homo sapiens monoclonal antibody, bispecific, bivalent
obertamig [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

OBERTAMIG

Synonyms and Mappings

Resources